Apply to work with a Muscle Intelligence Coach → https://muscleintelligence.com/apply

W. Bryan Hubbard is the CEO of Americans for Ibogaine, the organization he co-founded with former Texas Governor Rick Perry, and the reason ibogaine is now inside an FDA drug development pathway. He is also a conservative Kentucky attorney who once believed anyone holding a psychedelic belonged under the jail. What changed his mind was a single Scientific American article about psilocybin and alcohol dependency, a family history with alcohol, and a decade running two of Kentucky's largest government systems while the opioid epidemic that began in his ancestral home county killed nearly a million Americans. In this episode of the Muscle Intelligence Podcast, Ben Pakulski sits down with Hubbard to understand what psychedelic therapy actually does to the brain, how ibogaine interrupts opioid addiction in a single treatment without withdrawal, and why a medicine that has never had a recreational use is now the centerpiece of a federal and state partnership.

This is a conversation about the new frontier of mental health treatment for anyone who has watched addiction, PTSD, depression, or trauma take someone they love, and for anyone in the performance world who wants to understand what these medicines are before they arrive in the U.S. medical system. Hubbard explains the difference between a drug and a medicine, why psychedelics carry a built-in anti-addictive property, how ibogaine differs from psilocybin, ayahuasca, MDMA and 5-MeO-DMT, who should never take it, and what the executive order signed in April means for how soon psilocybin therapy, MDMA therapy and ibogaine treatment reach patients. He also covers the neuroregenerative research pointing toward traumatic brain injury and Parkinson's, and why natural sources have to survive the arrival of Western medical demand.

5 Key Takeaways

What happens in the 36 to 48 hours after an ibogaine treatment, and why Hubbard calls it an addiction interrupter rather than a cure.
The difference between a drug and a medicine, and the built-in property of psychedelics that makes them nearly impossible to abuse.
Why ibogaine has no recreational use, and what that has to do with why you've never heard of it.
Which psychedelic medicines are likely a year from prescription in the U.S., and which one is still years out.
Who ibogaine is not for, and why Hubbard says no one should ever order it online.

Chapters

0:00 Why a Performance Podcast Is Talking About Psychedelics
10:16 What Plant Medicine Changed About How He Sees People
19:04 The Opioid Epidemic and the Discovery of Ibogaine
29:47 From Kentucky to Texas to the Executive Order
40:02 Who Ibogaine Is Not For, and Medicine vs. Drug
46:15 Why Each Psychedelic Is Different
52:16 The Timeline: What's Coming and When
56:47 Natural vs. Synthetic and the Supply Chain Problem

Connect with Bryan Hubbard

Website – https://www.wbryanhubbard.com

Americans for Ibogaine – https://www.americansforibogaine.org

X – https://x.com/w_bryan_hubbard

Instagram – https://www.instagram.com/w_bryan_hubbard/

LinkedIn – https://www.linkedin.com/in/w-bryan-hubbard